Advertisement

Topics

Ocular Therapeutix reports $16 million quarterly loss

08:18 EDT 19 Jun 2017 | Healio

Ocular Therapeutix reported a net loss of $16 million, or $0.58 per share, in the first quarter of 2017 compared with a net loss of $10.8 million, or $0.44 per share, in the first quarter of 2016, according to a company press release.Total costs and operating expenses for the quarter totaled $16.1 million compared with $11 million in 2016’s first quarter, with research and development costs decreasing from $7.1 million in 2016’s first quarter to $6.7 million in 2017.

Original Article: Ocular Therapeutix reports $16 million quarterly loss

NEXT ARTICLE

More From BioPortfolio on "Ocular Therapeutix reports $16 million quarterly loss"

Advertisement
Quick Search
Advertisement
Advertisement